Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Anica Sabljic"'
Autor:
Marko Lucijanic, Ivan Krecak, Ena Soric, Anica Sabljic, Davor Galusic, Hrvoje Holik, Vlatka Perisa, Martina Moric Peric, Ivan Zekanovic, Josipa Budimir, Rajko Kusec
Publikováno v:
Life, Vol 14, Iss 4, p 523 (2024)
Aim: To investigate the prognostic contribution of absolute neutrophil (ANC), lymphocyte (ALC), platelet count and their ratios, neutrophil–lymphocyte ratio (NLR) and platelet–lymphocyte ratio (PLR), to thrombotic risk in patients with prefibroti
Externí odkaz:
https://doaj.org/article/f29cde860d624bb4adeeb79a53310d33
Autor:
Ivan Krecak, Dragana Grohovac, Nikolina Vucenovic Basic, Monika Ceko, Karla Nizetic, Anica Sabljic, Hrvoje Holik, Davor Galusic, Ivan Zekanovic, Martina Morić Perić, Vlatka Perisa, Marko Lucijanic
Publikováno v:
HemaSphere, Vol 7, p e975318d (2023)
Externí odkaz:
https://doaj.org/article/95372950acb64ebba4982b0845b08e6a
Autor:
Marko Lucijanic, Ivan Krecak, Ena Soric, Anica Sabljic, Davor Galusic, Hrvoje Holik, Vlatka Perisa, Martina Morić Perić, Ivan Zekanovic, Rajko Kušec
Publikováno v:
HemaSphere, Vol 7, p e80756cf (2023)
Externí odkaz:
https://doaj.org/article/c8f92c1985d84efdab0d2ab554e8806a
Autor:
Marko Lucijanic, Petra Veic, Ivona Aric, Katarina Tupek, Ena Soric, Anica Sabljic, Josipa Vlasac Glasnovic, Tajana Stoos-Veic, Ivan Krecak, Rajko Kušec
Publikováno v:
HemaSphere, Vol 7, p e4479964 (2023)
Externí odkaz:
https://doaj.org/article/f2b1f3460f174929a5428f5d5cdbc54b
Autor:
Marko Lucijanic, Ivan Krecak, Ena Soric, Martina Sedinic, Anica Sabljic, Lovorka Derek, Ozren Jaksic, Rajko Kusec
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 11, Pp 1-5 (2021)
Externí odkaz:
https://doaj.org/article/132774046f3f4b67ab77267a714f00ba
Autor:
Petra Bistrovic, Anica Sabljic, Ivona Kovacevic, Tomislav Cikara, Tatjana Keres, Tomo Lucijanic, Josko Mitrovic, Diana Delic-Brkljacic, Sime Manola, Marko Lucijanic
Introduction: There are conflicting data on prior oral-anticoagulant (OAC) use and outcomes of hospitalized COVID-19 patients. Due to uncertainties regarding associated risks with the prior OAC use, we have investigated this issue in a large cohort o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b438a24431e8fa1d030b453774d4df6
https://doi.org/10.1016/j.ijcard.2022.11.051
https://doi.org/10.1016/j.ijcard.2022.11.051
Publikováno v:
Journal of cardiology.
Understanding and modifying thrombotic risk in patients with myeloproliferative neoplasms
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dbe5354cf51d7b81c3d9b033fadf1d89
https://pubmed.ncbi.nlm.nih.gov/36592886
https://pubmed.ncbi.nlm.nih.gov/36592886
Autor:
Marko Lucijanic, Ena Soric, Martina Sedinic Lacko, Anica Sabljic, Ivan Krecak, Petra Bistrovic, Ana Jordan, Sime Manola, Ozren Jaksic, Tomo Lucijanic, Lovorka Derek, Rajko Kusec
Publikováno v:
Journal of Medical Virology. 94:3509-3511
Correlations of red cell distribution width and survival of COVID-19 patients are presented in the paper.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f93340bb3830342c77b224d06110c375
https://doi.org/10.1002/jmv.27785
https://doi.org/10.1002/jmv.27785
Autor:
Marko Lucijanic, Ivan Krecak, Ena Soric, Anica Sabljic, Davor Galusic, Hrvoje Holik, Vlatka Perisa, Martina Moric Peric, Ivan Zekanovic, Rajko Kusec
Publikováno v:
Leukemia Research
Volume 119
Volume 119
Primary myelofibrosis (PMF), post-polycythemia vera (post-PV) and post-essential thrombocythemia (post-ET) secondary myelofibrosis (SMF) are chronic myeloproliferative neoplasms (MPNs) characterized by bone marrow fibrosis, splenomegaly and debilitat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7dfd57625258718458811a60fa6de5d0
https://urn.nsk.hr/urn:nbn:hr:105:524953
https://urn.nsk.hr/urn:nbn:hr:105:524953
Autor:
Marko Lucijanic, Ivana Jurin, Martina Sedinic Lacko, Ena Soric, Anica Sabljic, Ivan Krecak, Josko Mitrovic, Daniela Marelic, Zvonimir Kremer, Irzal Hadzibegovic, Tomo Lucijanic, Rajko Kusec
U radu su analizirane mogućnosti etabliranih skorova (IMPROVE, modificirani IMPROVE, IMPROVEDD, Padua i CHA2DS2-VASC) da predvide trombozu u hospitaliziranih bolesnika sa COVID-19.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86c9ed548f85aa9ea59969bb3c0a3658
https://doi.org/10.1016/j.thromres.2022.04.009
https://doi.org/10.1016/j.thromres.2022.04.009